| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/10/267:00 AM | -$0.85 | -$0.81GAAP | +4.7% | +10% | $0.28M | $0.60M | +115% | — | |
| Q2 '26 | 8/6/267:00 AM | -$0.84 | -$0.84GAAP | 0.0% | +14% | $1.88M | $0 | ⚠ Check | — | |
| Q1 '26 | 5/7/267:00 AM | -$0.79 | -$0.83GAAP | -5.1% | -24% | $4.00M | $0 | ⚠ Check | — | |
| Q4 '25 | 3/3/267:00 AM | -$0.87 | -$0.88GAAP | -1.1% | -44% | $2.30M | $0 | ⚠ Check | — | |
| Q3 '25 | 11/14/257:00 AM | -$0.85 | -$0.90GAAP | -5.9% | -36% | $0.05M | $0 | ⚠ Check | — | |
| Q2 '25 | 8/6/257:00 AM | -$0.66 | -$0.98GAAP | -48.5% | -63% | — | $0 | — | — | |
| Q1 '25 | 5/14/257:00 AM | -$0.71 | -$0.67GAAP | +5.6% | -14% | — | $0 | — | — |
⚠ Potential error in calculation, check manually. Reported revenue shows as zero, which usually means the figure is missing.
GAAP = diluted EPS as filed with the SEC.